AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Early neonatal mortality and timing of low risk births - Authors' reply
Authors: Heller, G Misselwitz, B Schmidt, S
Citation: G. Heller et al., Early neonatal mortality and timing of low risk births - Authors' reply, BR MED J, 322(7283), 2001, pp. 433-434
Effects of a modified maternal position during labour on fetal oxygenationmeasured by pulse oximetry
Authors: Schmidt, S Sierra, F Hess, C Neubauer, S Kuhnert, M Heller, G
Citation: S. Schmidt et al., Effects of a modified maternal position during labour on fetal oxygenationmeasured by pulse oximetry, Z GEBU NEON, 205(2), 2001, pp. 49-53
Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery
Authors: Kushner, BH Wolden, S LaQuaglia, MP Kramer, K Verbel, D Heller, G Cheung, NKV
Citation: Bh. Kushner et al., Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery, J CL ONCOL, 19(11), 2001, pp. 2821-2828
Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer
Authors: Kelly, WK Curley, T Slovin, S Heller, G McCaffrey, J Bajorin, D Ciolino, A Regan, K Schwartz, M Kantoff, P George, D Oh, W Smith, M Kaufman, D Small, EJ Schwartz, L Larson, S Tong, W Scher, H
Citation: Wk. Kelly et al., Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer, J CL ONCOL, 19(1), 2001, pp. 44-53
An adjustment for a post-randomization variable in the comparison of two treatments for survival
Authors: Heller, G
Citation: G. Heller, An adjustment for a post-randomization variable in the comparison of two treatments for survival, STAT MED, 20(22), 2001, pp. 3475-3485
Platelet activation through triathlon competition in ultra-endurance trained athletes: Impact of thrombin and plasmin generation and catecholamine release
Authors: Mockel, M Ulrich, NV Heller, G Rocker, L Hansen, R Riess, H Patscheke, H Stork, T Frei, U Ruf, A
Citation: M. Mockel et al., Platelet activation through triathlon competition in ultra-endurance trained athletes: Impact of thrombin and plasmin generation and catecholamine release, INT J SP M, 22(5), 2001, pp. 337-343
N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
Authors: Cheung, NKV Kushner, BH LaQuaglia, M Kramer, K Gollamudi, S Heller, G Gerald, W Yeh, S Finn, R Larson, SM Wuest, D Byrnes, M Dantis, E Mora, J Cheung, IY Rosenfield, N Abramson, S O'Reilly, RJ
Citation: Nkv. Cheung et al., N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age, MED PED ONC, 36(1), 2001, pp. 227-230
Reduction of stillbirth by quality assessment of antenatal screening. Are so many ultrasound and CTG examinations necessary?
Authors: Schmidt, S Misselwitz, B Heller, G
Citation: S. Schmidt et al., Reduction of stillbirth by quality assessment of antenatal screening. Are so many ultrasound and CTG examinations necessary?, GYNAKOLOGE, 34(2), 2001, pp. 102
Evaluating the influence of asphyxia on long term health outcome. New answers from old data
Authors: Heller, G Schnell, R Schmidt, S
Citation: G. Heller et al., Evaluating the influence of asphyxia on long term health outcome. New answers from old data, GYNAKOLOGE, 34(2), 2001, pp. 126-129
Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma
Authors: Morris, CD Gorlick, R Huvos, AG Heller, G Meyers, PA Healey, JH
Citation: Cd. Morris et al., Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma, CLIN ORTHOP, (382), 2001, pp. 59-65
Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes
Authors: Mockel, M Gerhardt, W Heller, G Klefisch, F Danne, O Maske, J Muller, C Stork, T Frei, U Wu, AHB
Citation: M. Mockel et al., Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes, CLIN CHIM A, 303(1-2), 2001, pp. 167-179
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoicacid
Authors: Coffey, DC Kutko, MC Glick, RD Butler, LM Heller, G Rifkind, RA Marks, PA Richon, VM La Quaglia, MP
Citation: Dc. Coffey et al., The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoicacid, CANCER RES, 61(9), 2001, pp. 3591-3594
Neuroblastoma metastatic to the central nervous system - The Memorial Sloan-Kettering Cancer Center experience and a literature review
Authors: Kramer, K Kushner, B Heller, G Cheung, NKV
Citation: K. Kramer et al., Neuroblastoma metastatic to the central nervous system - The Memorial Sloan-Kettering Cancer Center experience and a literature review, CANCER, 91(8), 2001, pp. 1510-1519
Pairwise rank-based likelihood for estimation and inference on the mixtureproportion
Authors: Heller, G Qin, J
Citation: G. Heller et J. Qin, Pairwise rank-based likelihood for estimation and inference on the mixtureproportion, BIOMETRICS, 57(3), 2001, pp. 813-817
Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: Relation to tumor location by magnetic resonance imaging
Authors: Balcer, LJ Liu, GT Heller, G Bilaniuk, L Volpe, NJ Galetta, SL Molloy, PT Phillips, PC Janss, AJ Vaughn, S Maguire, MG
Citation: Lj. Balcer et al., Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: Relation to tumor location by magnetic resonance imaging, AM J OPHTH, 131(4), 2001, pp. 442-445
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p
Authors: Mora, J Cheung, NKV Kushner, BH LaQuaglia, MP Kramer, K Fazzari, M Heller, G Chen, LS Gerald, WL
Citation: J. Mora et al., Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p, J MOL DIAGN, 2(1), 2000, pp. 37-46
Induction of Ab3 and Ab3 ' antibody was associated with long-term survivalafter anti-G(D2) antibody therapy of stage 4 neuroblastoma
Authors: Cheung, NKV Guo, HF Heller, G Cheung, IY
Citation: Nkv. Cheung et al., Induction of Ab3 and Ab3 ' antibody was associated with long-term survivalafter anti-G(D2) antibody therapy of stage 4 neuroblastoma, CLIN CANC R, 6(7), 2000, pp. 2653-2660
Early neonatal mortality asphyxia related deaths, and timing of low risk births in Hesse, Germany, 1990-8: observational study
Authors: Heller, G Misselwitz, B Schmidt, S
Citation: G. Heller et al., Early neonatal mortality asphyxia related deaths, and timing of low risk births in Hesse, Germany, 1990-8: observational study, BR MED J, 321(7256), 2000, pp. 274-275
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide
Authors: Camacho, LH Soignet, SL Chanel, S Ho, R Heller, G Scheinberg, DA Ellison, R Warrell, RP
Citation: Lh. Camacho et al., Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide, J CL ONCOL, 18(13), 2000, pp. 2620-2625
C-reactive protein as an independent marker of prognosis in patients with acute coronary syndrome: comparison with cardiac troponin T
Authors: Mockel, M Heller, G Muller, C Klefisch, FR Riehle, M Searle, J Frei, U Stork, T
Citation: M. Mockel et al., C-reactive protein as an independent marker of prognosis in patients with acute coronary syndrome: comparison with cardiac troponin T, Z KARDIOL, 89(8), 2000, pp. 658-666
Clinical usefulness of pulse oximetry in the fetus with non-reassuring heart rate pattern?
Authors: Schmidt, S Koslowski, S Sierra, F Meyer-Wittkopf, M Heller, G
Citation: S. Schmidt et al., Clinical usefulness of pulse oximetry in the fetus with non-reassuring heart rate pattern?, J PERIN MED, 28(4), 2000, pp. 298-305
Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage
Authors: Hesse, L Schroeder, B Heller, G Kroll, P
Citation: L. Hesse et al., Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage, RETINA, 20(5), 2000, pp. 500-505
The phase II/III transition: Toward the proof of efficacy in cancer clinical trials
Authors: Fazzari, M Heller, G Scher, HI
Citation: M. Fazzari et al., The phase II/III transition: Toward the proof of efficacy in cancer clinical trials, CONTR CL TR, 21(4), 2000, pp. 360-368
Clinical states in prostate cancer: Toward a dynamic model of disease progression
Authors: Scher, HI Heller, G
Citation: Hi. Scher et G. Heller, Clinical states in prostate cancer: Toward a dynamic model of disease progression, UROLOGY, 55(3), 2000, pp. 323-327
Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin
Authors: May, C Rivella, S Callegari, J Heller, G Gaensler, KML Luzzatto, L Sadelain, M
Citation: C. May et al., Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin, NATURE, 406(6791), 2000, pp. 82-86
Risultati: 1-25 | 26-43